about
Samuel Goldflam (1852-1932) - promoter of modern neurology and his contribution to urologyThe incidence of renal cancer in Polish National Cancer Registry: is there any epidemiological data we can rely on?Anaesthesia of the posterior urethra and pain reduction during cystoscopy - a randomized controlled trial.The time from diagnosis of bladder cancer to radical cystectomy in Polish urological centres - results of CysTiming Poland study.Timing of radical cystectomy in Central Europe - multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patientsUrothelial bladder carcinoma in young patients is characterized by a relatively good prognosisLack of evidence for increased level of circulating urothelial cells in the peripheral blood after transurethral resection of bladder tumors.Renal function and adaptive changes in patients after radical or partial nephrectomy.A prospective, randomized trial comparing the use of KTP (GreenLight) laser versus electroresection-supplemented laser in the treatment of benign prostatic hyperplasiaPatterns of care in patients with muscle-invasive bladder cancer - a retrospective cohort study.Kidney removal: the past, presence, and perspectives: a historical review.Spontaneous regression of renal cell carcinomaExtent of lymphadenectomy in patients with bladder cancer undergoing radical cystectomy - a multi-institutional analysis.Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria: A Systematic Review.Stage of bladder cancer in Central Europe - Polish perspective.Blood loss during laparoscopic radical prostatectomy - is it significant or not?Endoscopic appearance of a tumor can predict the stage of bladder cancer.Factors affecting one-year survival after radical cystectomy: A prospective study.Predictors and prognostic implications of clinical decisions in patients with primary high-risk non-muscle-invasive bladder cancer - results of a cross country retrospective study.Comparison of pathological staging and grading of urothelial bladder carcinoma in post-transurethral resection and post-radical cystectomy specimens.Catheter-associated bacterial flora in patients with benign prostatic hyperplasia: shift in antimicrobial susceptibility patternThe TaHG bladder cancer - the devil is as black as he is paintedAuthor'S replyInterobserver variability of Clavien-Dindo scoring in urologyRe: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- andA stone pushed back to the collecting system - long therapeutic path in centers with limited access to flexible instrumentsRe: Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus CalmetteAre There Differences in Toxicity and Efficacy between Various Bacillus Calmette-Guerin Strains in Bladder Cancer Patients? Analysis of 844 PatientsInfluence of Transurethral Resection of Bladder Cancer on Sexual Function, Anxiety, and DepressionNew predictive nomograms for non-muscle-invasive bladder cancer: it is all about the detailsExpression of E-cadherin, β-catenin, and epithelial membrane antigen does not predict survival in patients with high-risk non-muscle-invasive bladder cancerThe Optimal Timing of Restaging Resection before Introduction of Bacillus Calmette-Guerin Immunotherapy in Patients with High-Risk Non-Muscle-Invasive Bladder CancerTGF-β and microRNA Interplay in Genitourinary CancersA systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette-Guérin immunotherapyScented Candles as an Unrecognized Factor that Increases the Risk of Bladder Cancer; Is There Enough Evidence to Raise a Red Flag?Surgical treatment for renal masses in the elderly: analysis of oncological, surgical and functional outcomesBimanual palpation for staging of bladder cancer-clinical use and its predictorsLetter to the editor
P50
Q28659207-F6344D3F-0578-4BF2-823E-319E21C2741CQ30854594-C9CDC889-38A6-4C4A-808D-2548538668A7Q33581492-07BCCD32-5DF3-4D32-A64F-2D13DA3CA118Q35028256-886682BA-1AC3-4BF4-8167-1A403AD69904Q35533822-FDF68EF9-836C-4B62-A9B9-BC103B1FB059Q35764916-91450025-78E6-45DB-8BC3-DB069DA79D76Q35981404-09B41F92-1388-4D17-BA11-85150BB22C79Q35981442-53BD464A-4453-40CF-A77A-849FFBEC46BEQ36262050-6D436B9A-A97F-4935-B439-82A1B7FB4BC1Q37274375-9CB3BEB4-538D-4967-B4DB-D83912875294Q37822329-6D54AAA2-E4BC-4B91-9C02-A2011908F887Q38116013-B4476E51-3BEA-4D0F-84D8-4555C03AFF65Q38996290-0E6DDB47-B147-4327-9B84-E042498FBD82Q39364584-16D00BA4-BBF6-4F0F-B88C-C88ECD6DF6FBQ39705451-7D165899-5E1A-426C-95A3-EBA7477B5D12Q41948787-ABE55ACA-131F-4E8C-AA83-4920D85B9485Q42357939-01D188E7-2C28-4E75-A96F-97A5621DEEA5Q46181356-2D5B9230-CF22-452D-909E-16C20191B3D6Q50095840-68925B92-EDD8-4567-9741-76941D718C20Q51053993-FF4138F5-B4B3-455B-BEAB-3A7C81EA98D7Q59336379-34CFBB81-EEE2-4A6B-8314-CE105510B2D1Q64230425-B8D0D9C4-B440-4EB6-85F6-FAF15A5FEE1FQ87192669-3EA7A5A9-8950-42B8-A920-1370A3C96E22Q87414160-07192E40-9904-45E3-AC31-6BCDCC17BB00Q87904601-3220FB4D-EA40-4A29-93A8-0354CB2BA749Q90431416-23260296-A14D-40BA-8F6E-4712509675B4Q91321959-5A32CDA9-4052-41C1-9FC1-B075DE11BC76Q91510923-37F653FF-5A72-4B60-8B82-7D1AF2D59A9FQ91644483-EF231E66-A6AC-49C0-AFCC-522DB94AE19DQ91694742-381BC392-53A8-4E5E-8CA8-3BD7500723C4Q91871939-817423D5-BB16-44DC-BB2A-DE34B4ED8CD8Q91886705-176F942E-11BB-45FE-835D-9EC3E36FF5D5Q92012224-60DB4D16-D18B-4FF4-8ABF-11D59DD6354BQ92356755-95743869-BA66-45FF-9187-730DCE4C3DE1Q92533205-AEF2CA9B-BB53-4EE3-91D1-ACC52D201B2DQ92625843-F2C124A5-E371-4B4A-AE54-04083F795E4FQ93367424-85C7D684-87C0-4885-8497-201FB5544C9EQ93607515-E38FB70A-E752-47F0-BD7A-3BFC9A22FB95
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sławomir Poletajew
@ast
Sławomir Poletajew
@en
Sławomir Poletajew
@es
Sławomir Poletajew
@nl
type
label
Sławomir Poletajew
@ast
Sławomir Poletajew
@en
Sławomir Poletajew
@es
Sławomir Poletajew
@nl
prefLabel
Sławomir Poletajew
@ast
Sławomir Poletajew
@en
Sławomir Poletajew
@es
Sławomir Poletajew
@nl
P106
P1153
36444279300
P31
P496
0000-0001-7664-9816